Ban Bian Lian (Chinese Lobelia, Lobelia)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Ban Bian Lian?

  Our record carries two ranges from two references: 10–20 g of the dried herb (30–60 g fresh in decoction), and a more conservative 3–15 g in decoction. The wide spread is characteristic of this herb — the very large figures belong to the historical acute snakebite and ascites uses, not to routine prescribing.

  • Dried herb: 10–20 g.
  • Larger decoction figure: 30–60 g — the high end reported for the acute traditional applications.
  • Conservative range: 3–15 g in decoction.
  • External use. Older texts describe the fresh plant applied topically to bites and stings alongside internal use.

  Note: the two recorded ranges genuinely differ (3–15 g versus up to 60 g). We take this as a real difference in reference practice rather than an error — the larger figures track historical acute-use reports — and both are retained as our record has them.

  Reference information only, not a prescription. Snakebite is a medical emergency; nothing here is a substitute for emergency care and antivenom.

  Source: our own herb record (both recorded ranges, and the external-use note). Reference only — not a prescription.

Chinese Herb Contraindications & Cautions

• Are there cautions for Ban Bian Lian?

  Our record gives one clear traditional contraindication: do not use it for oedema that arises from deficiency. This is a draining herb. Where fluid accumulates because the body is too depleted to move it, draining further is the wrong direction and can deepen the deficiency.

  • Deficiency-type oedema — contraindicated per our record.
  • Pregnancy and breastfeeding — we found no reliable safety data either way, so no position is asserted here; professional advice applies.
  • Snakebite is an emergency. The traditional antivenom use is documented history and should not displace emergency medical care or antivenom.
  • Dose ceilings matter. The very large historical doses recorded for acute use are not routine doses; see the dosage section.
  • Professional supervision. Our record documents overdose effects (see toxicity); this is not a casual self-prescribing herb.

  Source: our own herb record (deficiency-oedema contraindication, overdose description). Neutral reference notes, not a safety guarantee.

Chinese Herb Toxicity & Overdose

• Is Ban Bian Lian toxic?

  Our record describes it as toxic in excess, listing an overdose picture of nausea, headache, diarrhoea, salivation, raised blood pressure, agitation, muscle contraction, a pulse that slows then accelerates, spasms, dilated pupils and, in severe cases, respiratory paralysis. That is a serious profile and the dose ceilings should be respected. What is genuinely open to question is the compound our record attributes it to.

  Discrepancy — the lobeline question. Our record states that Ban Bian Lian “contains a powerful alkaloid called Lobeline,” and the overdose description above matches the classical picture of lobeline poisoning from Western lobelia (Lobelia inflata). Published sources conflict on whether Lobelia chinensis contains lobeline at all:

  • Against: a dedicated HPLC/Q-TOF mass-spectrometry profiling study compared Lobelia chinensis directly with Lobelia inflata and concluded that lobeline is absent from L. chinensis; the title of the paper states the finding explicitly. Other piperidine alkaloids, alkaloid–lignan hybrids, flavonoids and polyacetylenes were identified.
  • For: an earlier review article lists lobelanidine, lobeline and lobelanine among the constituents reported for L. chinensis.
  • Our reading: the analytical study is the stronger evidence — it was designed to answer this exact question and used a direct comparison against the lobeline-containing species. The review reflects the older assumption that the whole genus shares the alkaloid.

  We therefore do not assert lobeline as the toxic principle of Ban Bian Lian. The overdose description in our record is retained as recorded, and the attribution to lobeline is flagged for owner review rather than rewritten. Practically, the caution stands either way: the herb has documented overdose effects and defined dose ceilings.

  Source: our own herb record (overdose description and existing lobeline attribution); absence of lobeline in Lobelia chinensis, PMID 30544710 (PMC 6321420); constituent list including lobeline, PMID 24636059; alkaloid chemistry of L. chinensis, PMID 24444893. Reference note only.

Herb-Drug Interactions

• Does Ban Bian Lian interact with medications?

  No human interaction studies were located; the one caution our record carries is a plausible pharmacological overlap rather than a documented event. Our record notes that Ban Bian Lian has a diuretic effect and should therefore be used carefully alongside diuretic drugs including furosemide (Lasix), bumetanide (Bumex) and torsemide (Demadex) — the concern being additive fluid and electrolyte loss.

  • Diuretics — theoretical additive effect on fluid and electrolyte balance. Reasonable practitioner caution; not a demonstrated clinical interaction.
  • What is not documented. We found no published pharmacokinetic or clinical interaction study for Lobelia chinensis with any drug. Interaction data reported for Western lobeline — including its transporter and P-glycoprotein activity — belongs to Lobelia inflata chemistry and is not transferable here, particularly given the unresolved question of whether this species contains lobeline at all.
  • Anyone on diuretics, or being managed for oedema, ascites or liver disease, should have this herb reviewed by their prescriber.

  Source: our own herb record (diuretic caution); species-chemistry separation per PMID 30544710 (PMC 6321420). Reference information, not clinical advice.

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Ban Bian Lian (Lobelia chinensis)?

  Yes, but it is modest and almost entirely preclinical — chemistry, cell and animal work, with no controlled human trials located. The most consequential paper for readers of this page is analytical rather than therapeutic: a systematic HPLC/Q-TOF mass-spectrometry profile of the herb, the first of its kind, which identified piperidine alkaloids, alkaloid–lignan hybrids, flavonoids, polyacetylenes and other constituents — and established that lobeline, the famous Lobelia alkaloid, is not among them.

  • Chemistry. Isolation work has described new 2,6-disubstituted piperidine alkaloids and a new polyacetylene from the whole plant, with two compounds showing moderate cytotoxicity against two human lung cancer cell lines in vitro.
  • Oncology (preclinical). A 2024 study reported that Lobelia chinensis extract inhibited hepatocellular carcinoma progression via PTEN/AKT signalling in cell and animal models. Laboratory work only.
  • Skin barrier (preclinical). Extract and its flavonoid diosmetin improved atopic-dermatitis-like changes in a model through SPINK5/LEKTI regulation of skin barrier function.
  • Metabolic (computational). A network-pharmacology study using GC/MS identified 208 metabolites and proposed anti-diabetic targets. This is a modelling exercise, not evidence of clinical effect.
  • Traditional pharmacology summarised. A review collects reported diuretic, choleretic, respiratory-stimulant, anti-venom, antibacterial and anticancer activities for the species — useful as a map of what has been investigated, not as proof of any of it.

  Nothing here supports a therapeutic claim. The research is best read as chemistry and mechanism-hunting; the herb’s standing rests on its traditional record, and the strongest practical takeaway from the literature is the species-identity correction on lobeline.

  Sources: PMID 30544710 (PMC 6321420) chemical profiling and absence of lobeline; PMID 24444893 alkaloid and polyacetylene isolation; PMID 37429502 hepatocellular carcinoma model; PMID 35955819 (PMC 9369373) atopic dermatitis and diosmetin; PMID 32265717 (PMC 7099657) network pharmacology; PMID 24636059 constituents and activity review. Research context, not a therapeutic claim.

Chinese Herb Notes

• What is the difference between Ban Bian Lian and Ban Zhi Lian?

  They are completely different plants from different families, and the names differ by one syllable — this is one of the easiest mix-ups in the whole materia medica. Ban Bian Lian is Lobelia chinensis (Campanulaceae). Ban Zhi Lian is Scutellaria barbata, barbat skullcap (Lamiaceae, the mint family). They share nothing but a rhyme.

  • Ban Bian Lian — Lobelia chinensis. Our records: sweet, neutral; Heart, Lung and Small Intestine channels; category = herbs that regulate water and drain dampness. Signature uses: oedema/ascites and snakebite.
  • Ban Zhi Lian — Scutellaria barbata. Our records: spicy, bitter, cold; Large Intestine, Liver, Lung and Stomach channels; category = herbs that clear heat and eliminate toxins. Signature uses: clearing heat and resolving toxicity, invigorating blood and reducing swelling.
  • Quick tell: different taste and temperature (sweet/neutral versus bitter/cold), different category, different family. If a source treats them as interchangeable, it is wrong.

  Is Ban Bian Lian the same as the lobelia sold in the West?

  No. Western herbal “lobelia,” also called Indian tobacco, is Lobelia inflata — a different species with a different chemistry, a different traditional use (respiratory and emetic) and a considerably harsher toxicity profile. Ban Bian Lian is Lobelia chinensis. Same genus, different plant, different medicine. The Lobelia inflata literature — including everything written about the alkaloid lobeline — should not be read across to Ban Bian Lian. See the toxicity section, where analytical work bears directly on this.

  How does Ban Bian Lian compare with Bai Hua She She Cao?

  Both treat snakebite and toxin, reduce swelling and clear heat; the split is in the secondary action. Ban Bian Lian is the better diuretic. Bai Hua She She Cao is the better choice for painful, dribbling urination associated with damp-heat.

  Note on our identity field: our record gives the Latin as Herba Lobeliae Chinensis Gum Radice. The conventional pharmaceutical form is “cum Radice” (with the root) — “Gum” appears to be a long-standing transcription slip for “cum.” The meaning (whole plant collected with the root) is not in doubt. The field is left unchanged and flagged for owner review.

  Source: our own herb records for Ban Bian Lian and Ban Zhi Lian (species, properties, channels, categories) and our own record’s differentiation note on Bai Hua She She Cao; species separation of Lobelia chinensis from Lobelia inflata per PMID 30544710 (PMC 6321420). Cross-referenced against multiple online sources.